Why Do Zebras Have Stripes? New Study Makes Temperature Connection
UCLA biologist Brenda Larison and colleagues visited zebra populations throughout Africa and studied stripe patterns. The most important factors affecting stripes: temperature.
Endangered monkeys in the Amazon are more diverse than previously thought, UCLA study finds
Recent research led by UCLA Life Scientists, Michael Alfaro and Jessica Lynch Alfaro, is changing how we think about endangered monkeys in the Amazon.
Researchers shed light on how ‘microbial dark matter’ might cause disease
Breakthrough by scientists from UCLA, J. Craig Venter Institute, and U of Washington pioneer studies of difficult to cultivate, elusive bacteria in our bodies.
A Possibility for Restoring Lost Memories
Research led by UCLA neurobiologist David Glanzman,indicates that lost memories can be restored.
UCLA ecologists save endangered turtles weakened by the drought
Biologists from UCLA La Kretz Center for California Conservation Science help to save and rehabilitate endangered turtles in Southern California.
Loss of a chemical tag on RNA keeps embryonic stem cells in suspended animation
A team of scientists, including UCLA researchers, has discovered a novel mechanism of RNA regulation in embryonic stem cells.
UCLA Professor Crosbie-Watson Granted Coalition Duchenne Lotus Award
Newport Beach-based Coalition Duchenne has granted its 2014 Lotus Award to professor Rachelle Crosbie-Watson from the University of California, Los Angeles (UCLA) in recognition of her outstanding work in education, research, and awareness for Duchenne muscular dystrophy
UCLA Professor wins Lotus Award for Outstanding Contribution to Duchenne Muscular Dystrophy Education, Research and Awareness
Coalition Duchenne, a Newport Beach based charity committed to raising awareness about Duchenne muscular dystrophy and funding for research, has awarded UCLA professor, Rachelle Crosbie-Watson with its 2014 Lotus Award..
UCLA Researchers Announce Gene Therapy Cure for 18 ‘Bubble Baby’ Patients
A team led UCLA life scientist, Dr. Donald Kohn, developed the breakthrough that cured 18 children who had adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID)